Old Web
English
Sign In
Acemap
>
authorDetail
>
Kaitlyn L OShea
Kaitlyn L OShea
Northwestern University
Internal medicine
Pembrolizumab
Chemotherapy
Medicine
Adverse effect
2
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PD-L1 Pathway Markers and Chromosome 9p24.1 Alterations in Patients with Classic Hodgkin Lymphoma Treated with Frontline Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy
2020
Blood
Pamela B. Allen
Xinyan Lu
Qing C. Chen
Liron Barnea Slonim
Madina Sukhanova
Hatice Savas
Joan S. Chmiel
Kaitlyn L OShea
Andrew M. Evens
Ranjana H. Advani
Barbara Pro
Reem Karmali
Brett Alan Palmer
Jeffrey Bearden
Eric Mou
Gary Dillehay
Leo I. Gordon
Jane N. Winter
Show All
Source
Cite
Save
Citations (0)
Pembrolizumab followed by AVD in untreated early unfavorable and advanced stage classical Hodgkin lymphoma.
2020
Blood
Pamela B. Allen
Hatice Savas
Andrew M. Evens
Ranjana H. Advani
Brett Alan Palmer
Barbara Pro
Reem Karmali
Eric Mou
Jeffrey Bearden
Gary Dillehay
Robert Bayer
Robert M. Eisner
Joan S. Chmiel
Kaitlyn L OShea
Leo I. Gordon
Jane N. Winter
Show All
Source
Cite
Save
Citations (18)
1